fluoxetine has been researched along with aica ribonucleotide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, G; Liu, W; Shan, E; Shang, W; Wu, L; Xi, T; Xiong, J; Yang, H; Yang, J | 1 |
| Ji, L; Li, H; Liu, W; Wang, Y | 1 |
2 other study(ies) available for fluoxetine and aica ribonucleotide
| Article | Year |
|---|---|
Fluoxetine suppresses AMP-activated protein kinase signaling pathway to promote hepatic lipid accumulation in primary mouse hepatocytes.
Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Blotting, Western; Cells, Cultured; Fluorescent Antibody Technique; Fluoxetine; Hepatocytes; Hypoglycemic Agents; Lipogenesis; Lipolysis; Male; Mice; Mice, Inbred ICR; Protein Serine-Threonine Kinases; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleotides; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Signal Transduction; Sterol Regulatory Element Binding Protein 1 | 2014 |
The Role of Nitric Oxide in the Antidepressant Actions of 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside in Insulin-Resistant Mice.
Topics: Adenylate Kinase; Aminoimidazole Carboxamide; Animals; Antidepressive Agents; Combined Modality Therapy; Corticosterone; Depressive Disorder; Diet, High-Fat; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme Activation; Fluoxetine; Imipramine; Insulin Resistance; Ketamine; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Physical Conditioning, Animal; Prefrontal Cortex; Ribonucleotides; Triazenes | 2016 |